Brain Tumors

• CLINICAL_TRIALS research · 2010-10-27
  Clinical Trial Update: CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan [Phase 2]

  Phase 2 clinical trial update evaluating CT-322 with irinotecan for recurrent glioblastoma multiforme; sponsored by Adnexus (a Bristol-Myers…

• CLINICAL_TRIALS trial_result · 2009-10-14
  Clinical Trial Update: SU5416 in Treating Children With Recurrent or Progressive Brain Tumors [Phase 1]

  A Phase 1 trial evaluating SU5416 (semaxanib) in children with recurrent or progressive brain tumors has been terminated.

• CLINICAL_TRIALS trial_result · 2009-01-13
  Clinical Trial Update: Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma [Phase 1]

  This document reports the completion of a Phase 1 clinical trial evaluating atrasentan for patients with progressive or recurrent malignant …

• CLINICAL_TRIALS trial_result · 2008-11-19
  Clinical Trial Update: Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation [Phase 4]

  A Phase 4 study evaluating prophylactic itraconazole to prevent fungal infections in patients receiving high-dose chemotherapy and autologou…

• CLINICAL_TRIALS trial_result · 2007-04-27
  Clinical Trial Update: Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients [Phase 3]

  Phase 3 trial evaluating dalteparin for primary prophylaxis of venous thromboembolism in brain tumor patients has completed; no results are …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.